fda warning letter bpc-157 2023 Heal or Harm: Body Protective Compound-157 in the Gray Zone Trends In FDA FY2023 Inspection-Based
Description
Pharmaceutical Research 2010
Not everyone needs to reach the highest doses
Piperine was also included in the not prohibited group, based on a description by AIS found in the characterization of curcumin from group B, which states, curcumin is an unstable compound and its bioavailability is very poor in its unmodified form
Dont let poor supplies dilute your success
